XOMA Corporation (XOMAO) Stock Analysis

XOMA Corporation (XOMAO) is a publicly traded company in the HEALTHCARE sector. It trades at $25.36, a price-to-earnings ratio of 25.31. This page summarizes the public market data, fundamentals, and frequently asked questions for XOMAO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

XOMA Corporation currently has a Neutral sentiment score of 0.04.

About XOMA Corporation

XOMA Corporation is a prominent biotechnology royalty aggregator dedicated to the discovery and development of innovative therapeutic candidates globally, with a presence in the United States, Europe, and the Asia Pacific region. Based in Emeryville, California, the company actively partners with leading biopharmaceutical firms to enhance its portfolio of royalty-bearing assets. Utilizing its extensive knowledge in drug development and licensing, XOMA focuses on creating value for stakeholder...

GNG Research Analysis

GNG Research scores XOMA Corporation (XOMAO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XOMAO.

Frequently Asked Questions

Does XOMAO pay dividends?

XOMA Corporation (XOMAO) does not currently pay a regular dividend.

What is XOMAO's P/E ratio?

XOMA Corporation has a price-to-earnings (P/E) ratio of 25.31.